List of insiders holdings for Verve Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| GV 2017 GP L.L.C. GV 2017 GP L.P. GV 2017 L.P. GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. Alphabet Inc. Member of 10% Group | 2023-12-11 16:16:31 | 12,349,086 0 | 12,349,086 | Form 13G |
| Yeshwant Krishna Director 10% Owner | 2023-12-05 16:30:09 | 0 12,168,489 | 12,168,489 | Form 4 |
| FMR LLC See Remark 1 | 2023-12-11 09:09:54 | 3,803,214 0 | 3,803,214 | Form 13G |
| Biomatics Capital Partners L.P. 10% Owner | 2021-06-16 20:07:26 | 2,597,464 0 | 2,597,464 | Form 3 |
| Casdin Partners Master Fund L.P. 10% Owner | 2021-06-22 17:12:46 | 2,417,596 0 | 2,417,596 | Form 4 |
| Redmile Group LLC Green Jeremy 10% Owner | 2021-06-23 16:16:18 | 0 1,936,530 | 1,936,530 | Form 4 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 2022-02-04 08:53:42 | 1,871,679 0 | 1,871,679 | Form 13G |
| GV 2023 GP L.L.C. GV 2023 GP L.P. GV 2023 L.P. Alphabet Inc. Member of 10% Group | 2023-12-05 16:50:59 | 0 1,800,000 | 1,800,000 | Form 3 |
| Broad Institute Inc. 10% Owner | 2021-06-23 18:13:03 | 1,197,614 0 | 1,197,614 | Form 4 |
| Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 2021-06-23 16:02:50 | 0 984,224 | 984,224 | Form 4 |
| Logos Global Management LP 10% Owner | 2021-06-22 17:21:53 | 370,000 443,265 | 813,265 | Form 4 |
| Novo Holdings A/S 10% Owner | 2021-06-22 17:17:32 | 793,265 0 | 793,265 | Form 4 |
| Kathiresan Sekar Chief Executive Officer | 2024-02-16 16:30:29 | 658,000 0 | 658,000 | Form 4 |
| Casdin Private Growth Equity Fund L.P. 10% Owner | 2021-06-22 17:12:49 | 620,571 0 | 620,571 | Form 4 |
| Beam Therapeutics Inc. 10% Owner | 2021-06-23 16:30:16 | 546,970 0 | 546,970 | Form 4 |
| ADELMAN BURT A Director | 2024-02-09 17:00:21 | 0 428,326 | 428,326 | Form 5 |
| Rozen Israel 10% Owner | 2021-06-16 19:38:34 | 409,626 0 | 409,626 | Form 3 |
| Ticho Barry 10% Owner | 2021-06-16 19:31:11 | 409,626 0 | 409,626 | Form 3 |
| Joung Jae Keith 10% Owner | 2021-06-16 19:42:52 | 0 409,625 | 409,625 | Form 3 |
| Bellinger Andrew Chief Scientific Officer | 2024-02-16 16:30:11 | 225,000 0 | 225,000 | Form 4 |
| Dorval Allison Chief Financial Officer | 2024-02-16 16:30:12 | 225,000 0 | 225,000 | Form 4 |
| Ashe Andrew D. See Remarks | 2024-02-16 16:30:34 | 186,000 0 | 186,000 | Form 4 |
| Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner | 2021-06-22 17:20:53 | 0 152,926 | 152,926 | Form 4 |
| Fiedorek Fred T. Chief Medical Officer | 2024-02-16 16:30:19 | 112,000 0 | 112,000 | Form 4 |
| Mikhail Sheila Director | 2023-06-20 17:00:07 | 26,642 0 | 26,642 | Form 4 |
| COATS LONNEL Director | 2023-06-20 17:00:14 | 26,642 0 | 26,642 | Form 4 |
| MacLean Michael F Director | 2023-06-20 17:00:20 | 26,642 0 | 26,642 | Form 4 |
| Cumbo Alexander Director | 2023-06-20 17:00:18 | 26,642 0 | 26,642 | Form 4 |
| Nickerson Joan Chief Administrative Officer | 2024-04-03 17:00:05 | 18,604 0 | 18,604 | Form 4 |
| Evans John M. Director | 2022-06-13 17:00:35 | 15,500 0 | 15,500 | Form 4 |
| Beaudoin Margaret Vice President, Finance | 2021-06-21 18:25:41 | 11,799 0 | 11,799 | Form 4 |
| ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 2023-02-13 16:08:56 | 0 0 | 0 | Form 13G |